Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Medicine Maker
  • Explore

    Explore

    • Latest
    • Features
    • Interviews
    • Business & Trends
    • Technology & Manufacturing
    • Product Profiles
    • White Papers

    Featured Topics

    • Biopharma
    • Small Molecules
    • Cell & Gene
    • Future of Pharma

    Issues

    • Latest Issue
    • Archive
    • Cell and Gene Therapy Supplement
  • Topics

    Topics

    • Drug Discovery
    • Development & Clinical
    • Formulation
    • Drug Delivery
    • Bioprocessing
    • Small Molecules
    • Cell and Gene
    • Facilities & Equipment
    • Outsourcing
    • Packaging
    • Supply Chain
    • Regulation & Standards
  • News & Blogs

    News & Blogs

    • Industry News
    • Research News
    • Blogs
  • Events
    • Live Events
    • Webinars
  • Community & Awards

    Community & Awards

    • Power List
    • Sitting Down With
    • Innovation Awards
    • Company of the Year Awards
    • Authors & Contributors
  • Multimedia
    • Video
    • Podcasts
    • eBooks
Subscribe
Subscribe
The Medicine Maker / Issues / 2016 / Articles / Nov / The Times They Are a-Changin’
Business & Regulation Technology and Equipment Business Practice Trends & Forecasts Technology & Manufacturing Business & Trends

The Times They Are a-Changin’

What impact will Brexit, a new US President, and a flood of new technologies have on the industry?

By Stephanie Vine 11/18/2016 1 min read

Share

Bob Dylan was seen as an unorthodox choice for the recipient of the 2016 Nobel Prize in literature – and he was also referenced by Robert Chew from Commissioning Agents Inc, at the ISPE’s recent Facilities of the Future event. Chew explained that the times are indeed changing, both inside and outside the pharma industry. But not all changes can be anticipated – the outcome of the UK’s referendum on its EU membership and the result of the US elections both defied the predictions of statisticians. Change was a key theme at the ISPE event and although discussions during the networking breaks often veered towards Brexit, the US elections, and the uncertain impact on science, the overall focus of the conference was on the positive changes shaping the industry, such as the development of exciting new technologies. Margaret Prendergast, a bioengineer at BioBots, discussed the possibilities of 3D printing in automating biology. We’ve delved into the potential of 3D printing in pharma manufacturing before in The Medicine Maker (1), but Prendergast focused on the area of organ printing, which could potentially revolutionize research and development, as well as the lives of patients waiting for transplants. Meanwhile, Tyler McQuade from the US Defense Advanced Research Projects Agency (DARPA) discussed progress in making both small- and large-molecule drugs on demand. He envisions a transportable box that can be taken to remote locations, including battlefields, where the push of a button manufactures the required medicine – we also covered this hot topic earlier this year (2).

Such technologies almost sound too futuristic to be true, but both Prendergast and McQuade assured attendees that progress is being made rapidly, with McQuade adding that a number of big pharma companies have already contacted DARPA to get involved with the work. Another technology briefly mentioned during the event was the advent of augmented reality and virtual reality in manufacturing – we discuss this in great detail in this month’s cover feature. These technologies are on the horizon and are worth watching closely, but other changes lie just around the corner. A key takeaway from the ISPE event was that if it can be automated, it will be automated. In fact, jokes were made that automation in the future will only require one man and a dog. The dog’s role will be to keep the man away from the automation, and the role of the man will be to feed the dog… Jokes aside, big changes are coming. No change is ever straightforward, but unlike politics, at least technological changes can be better planned for.

Stephanie Sutton
Editor

Newsletters

Receive the latest analytical science news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

References

  1. S Sutton, “A new dimension to medicine manufacture”, The Medicine Maker, 0815, 20-27 (2015). Accessible at http://bit.ly/1L3Xrlo J Strachan, “Biopharma battlefield”, The Medicine Maker, 0716, 12 (2016). Accessible at http://bit.ly/2cIBYYY

About the Author(s)

Stephanie Vine

Making great scientific magazines isn’t just about delivering knowledge and high quality content; it’s also about packaging these in the right words to ensure that someone is truly inspired by a topic. My passion is ensuring that our authors’ expertise is presented as a seamless and enjoyable reading experience, whether in print, in digital or on social media. I’ve spent fourteen years writing and editing features for scientific and manufacturing publications, and in making this content engaging and accessible without sacrificing its scientific integrity. There is nothing better than a magazine with great content that feels great to read.

More Articles by Stephanie Vine

False

Advertisement

Recommended

False

Related Content

Battle of the Superbugs
Drug Discovery Technology and Equipment
Battle of the Superbugs

December 1, 2014

0 min read

Can phage endolysins revolutionize the way bacterial infections are treated – and prevent drug resistance?

All a Big Game?
Business Practice Technology and Equipment Trends & Forecasts
All a Big Game?

November 6, 2014

0 min read

“Welcome to Big Pharma, where you can make a fortune and still maintain a healthy conscience. Or can you?”

Beware the Dragonfly
Business Practice Technology and Equipment Trends & Forecasts
Beware the Dragonfly

November 6, 2014

0 min read

Mysterious cyber attackers are hitting pharma manufacturing systems

Future Proofing Track and Trace
Standards & Regulation Technology and Equipment
Future Proofing Track and Trace

November 6, 2014

0 min read

The US is finally introducing regulation on drug serialization and traceability, but gaps remain that could leave patients vulnerable.

The Medicine Maker
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.